ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
IB
Imviva Bio at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Imviva Bio brings 4 presentations to ACR Convergence 2026 in Orlando. Its program centres on dual CD19/BCMA allogeneic CAR-T cell therapy for lupus and lupus nephritis, including deep B-cell depletion, immune reset and durable remission in refractory disease.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
IB Imviva Bio | |
A biotechnology company developing allogeneic CAR T-cell therapies for autoimmune diseases. | Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm |
Find decision makers at Imviva Bio
Tell us what you sell and we’ll find the people at Imviva Bio most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction